SlideShare a Scribd company logo
1 of 47
THE KEY TO MEANINGFUL USE STAGE 2
&
PQRS
PRESENTER: MARCIA FASTAG, MA, OTR/L, CMUP
Professional Services Consultant
Agenda
MU Core and Menu Measures with key changes between stages 1 and 2 including
exemptions.
• Proposed MU Changes
• Special emphasis will be placed on the following changes:
▪ CPOE
▪ Clinical Decision Support
▪ Patient Education
▪ Medication Reconciliation
▪ Summary of Care
▪ Transition of Care
PQRSCQM Crosswalk
5/15/2015 MU 2 & PQRS Seminar 2
MU Core Measures Stage 2 vs Stage 1 With Exclusions
EPs must satisfy the requirements of all 17 core objectives to
meet Stage 2 of Meaningful Use. The core objectives follow:
1. Use Computerized Provider Order Entry (CPOE) for more than 60 percent of medication, 30
percent of laboratory tests, and 30 percent of radiology orders directly entered into the medical
record. – STAGE 1 MEDICATION 30%
▪ EXCLUSION - CPOE for Medication, Laboratory, and Radiology Orders: Any EP who writes fewer than 100
medication, radiology, or laboratory orders.
▪ Under proposed 2015 rule Stage 1 providers could claim exclusion for lab/radiology and select Stage 1 CPOE
for medication orders
2. More than 50% of all permissible prescriptions written by the EP are compared to at least one
drug formulary STAGE 1 – 40%
▪ EXCLUSION – Prescribe less than 100 prescriptions during the recording period.
▪ Under proposed 2015 rule Stage 1 providers may report on Stage 1 objective
5/15/2015 MU 2 & PQRS Seminar 3
MU Core Measures Stage 2 vs Stage 1 With Exclusions
EPs must satisfy the requirements of all 17 core objectives to
meet Stage 2 of Meaningful Use. The core objectives follow:
3. Record demographics for more than 80 percent of all unique patients, including preferred
language, sex, race, ethnicity, date of birth. STAGE 1 50%
▪ NO EXCLUSION
▪ Under proposed 2015 rule providers would not have to report numerator/denominator.
4. Record and chart changes in vital signs for more than 80 percent of all unique patients,
including height/length and weight (no age limit); blood pressure (ages 3 and over); calculate
and display Body Mass Index (BMI); and plot and display growth charts for patients 0 to 20 years
of age, including BMI. STAGE 1 40%
▪ EXCEMPTION: Record Vital Signs: Any EP who (1) sees no patients 3 years of age or older is excluded from
recording blood pressure; (2) believes that all three vital signs of height/length, weight, and blood pressure have
no relevance to their scope of practice is excluded from recording them; (3) believes that blood pressure alone is
not relevant to the scope of practice is excluded from recording it; (4) believes that height/length and weight
alone are not relevant to the scope of the practice is excluded from recording them.
▪ Under proposed 2015 rule providers would not have to report numerator/denominator.
5/15/2015 MU 2 & PQRS Seminar 4
5. Record smoking status for more than 80 percent of patients 13 years of age or older. STAGE 1 50%
▪ EXCLUSION: Any EP who neither sees nor admits any patients 13 years of age or older.
▪ Under proposed 2015 rule providers would not have to report numerator/denominator.
6. Use Clinical Decision Support (CDS) to improve performance on high-priority health conditions. Implement five
CDS interventions related to four or more clinical quality measures and enable the functionality for drug-drug and
drug-allergy interaction checks. STAGE 1 one measure
▪ Under proposed 2015 rule Stage 1 providers may report on current Stage 1 objective.
7. Provide more than 50 percent of all unique patients the ability to view online, download, and transmit their health
information within four business days of the information being available to the EP. More than 5 percent of all
unique patients must view, download, or transmit their health information to a third party. STAGE 1 More than
50% of all patients of the EP who request an electronic copy of their health information are provided it within 3
business days
▪ EXCLUSION: Patient Electronic Access: Any EP who (1) neither orders nor creates any of the information listed for inclusion as part
of both measures—except for patient name, provider name, and office contact information—may exclude both measures; (2)
conducts 50 percent or more of patient encounters in a county where fewer than 50 percent of housing units have 3 Mbps broadband
availability according to the FCC may exclude only the second measure
▪ Measure #1 unchanged under 2015 proposed rule.
▪ Measure #2 threshold previously more than 5 percent proposed to change to ‘1’ patient.
5/15/2015 MU 2 & PQRS Seminar 5
8. Provide clinical summaries to patients for more than 50 percent of office visits within one business day. STAGE 1 –
3 days
▪ EXCLUSION: Clinical Summaries: Any EP who has no office visits.
▪ Under proposed 2015 rule providers would not have to report numerator/denominator.
9. Protect electronic health information created or maintained by the certified EHR technology through the
implementation of appropriate technical capabilities by conducting or reviewing a security risk analysis in
accordance with the requirements under 45 C.F.R. § 164.308 (a)(1).
▪ NO EXCLUSION
▪ Under proposed rule both Stage 1 and Stage 2 providers will need to address encryption.
• Microsoft 10 PRO includes device and file encryption via BitLocker, along with many other security enhancements
• Hardware-based encryption allows for improved performance, because a dedicated processor encrypts all data that is written to the
hard disk
• business smartphones that have a work / personal partition
• MS Office 365 (Outlook) can be used for end-to-end encryption, for $2/user/month, with Azure Rights Management
• For practices that need HIPAA-compliant file sharing, Sookasais affordable and convenient
• For practices that want to text PHI, TigerText is affordable and convenient
10. Incorporate more than 55 percent of all clinical lab-test results into certified EHR technology as structured data.
STAGE 1 40%
▪ EXCLUSION: Any EP who orders no lab tests where results are either in a positive/negative affirmation or numeric format.
▪ Under proposed 2015 rule providers would not have to report numerator/denominator.
5/15/2015 MU 2 & PQRS Seminar 6
11. Generate lists of patients by specific conditions to use for quality improvement, reduction of disparities,
research, or outreach.
▪ NO EXCLUSIONS
▪ Under proposed 2015 rule objective is removed.
12. Use EHR to identify and provide reminders for preventive/follow-up care for more than 10% of patients with
two or more office visits in the last 2 years STAGE 1 - More than 20% of all unique patients 65 years or older
or 5 years old or younger were sent an appropriate reminder during the EHR reporting period
▪ EXCLUSION: Any EP who has had no office visits in the previous 24 months
▪ Under proposed 2015 rule providers would not have to report numerator/denominator.
13. Patient-specific education resources identified by CEHRT are provided to patients for more than 10% of all
unique patients with office visits seen by the EP during the EHR reporting period.
▪ EXCLUSION: Any EP who has had no office visits
▪ Under proposed 2015 rule a Stage 1 provider may claim exclusion if education was not a planned menu objective.
5/15/2015 MU 2 & PQRS Seminar 7
14. The EP who receives a patient from another setting of care or provider of care, or who believes an encounter is
relevant, should perform medication reconciliation for more than 50 percent of patients.
▪ EXCLUSION: Any EP who was not the recipient of any transitions of care
▪ Under proposed 2015 rule a Stage 1 provider may claim exclusion if reconciliation was not a planned menu objective.
15. The EP who transitions their patient to another setting of care or provider of care or refers their patient to another
provider of care should provide summary of care record for each transition of care or referral
1. The EP who transitions or refers their patient to another setting of care or provider of care provides a summary of care record for more
than 50% of transitions of care and referrals
▪ Under proposed 2015 rule objective is removed.
2. The EP who transitions or refers their patient to another setting of care or provider of care provides a summary of care record either a)
electronically transmitted to a recipient using CEHRT or b) where the recipient receives the summary of care record via exchange
facilitated by an organization that is a NwHIN Exchange participant or is validated through an ONC-established governance mechanism
to facilitate exchange for 10% of transitions and referrals
▪ Under proposed 2015 rule Stage 1 providers may claim exclusion.
3. The EP who transitions or refers their patient to another setting of care or provider of care must either a) conduct one or more successful
electronic exchanges of a summary of care record with a recipient using technology that was designed by a different EHR developer
than the sender's, or b) conduct one or more successful tests with the CMS-designated test EHR during the EHR reporting period
▪ EXCLUSION: Any EP who transfers a patient to another setting or refers a patient to another provider less than 100 times is excluded
from all three measures.
▪ Under proposed 2015 rule objective is removed.
5/15/2015 MU 2 & PQRS Seminar 8
16. Capability to submit electronic data to immunization registries or Immunization Information Systems and actual
submission except where prohibited and in accordance with applicable law and practice
▪ EXCLUSION: Any EP who meets one or more of the following criteria may be excluded from this objective: (1) the EP does not
administer immunizations to any of the populations for which data is collected in their jurisdiction; (2) the EP operates in a jurisdiction
where no immunization registry is capable of accepting the data in the specific standards required for certification of the EHR; (3) the
EP operates in a jurisdiction where no immunization registry provides timely information on capability to receive immunization data; or
(4) the EP operates in a jurisdiction where no immunization registry can enroll additional EPs.
▪ Under 2015 proposed rule objective remains.
17. Use secure electronic messaging to communicate with more than 5 percent of unique patients on relevant health
information. (NEW)
▪ EXCLUSION: Any EP who has no office visits, or who conducts 50 percent or more of patient encounters in a county where fewer
than 50 percent of housing units have 3 Mbps broadband availability according to the FCC.
▪ Under proposed 2015 rule objective changed to self-attestation and minimum threshold removed.
5/15/2015 MU 2 & PQRS Seminar 9
EPs must meet 3 out of 6 of the menu objectives to demonstrate Stage 2
of Meaningful Use. All menu objectives must be achieved in accordance
with applicable law and practice. The menu objectives follow:
1. Capability to submit electronic syndromic surveillance data to public health agencies. (Same)
▪ EXCLUSION: Any EP that meets one or more of the following criteria may be excluded from this objective: (1) the EP is not in a
category of providers that collect ambulatory syndromic surveillance information on their patients; (2) the EP operates in a jurisdiction
where no public health agency is capable of receiving such data in the standards required by certified EHR technology; (3) the EP
operates in a jurisdiction where no public health agency provides timely information on capability to receive such data; or (4) the EP
operates in a jurisdiction where no public health agency that can accept such data can enroll additional EPs.
▪ Under 2015 proposed rule objective remains.
2. Record at least one electronic progress note in patient records for more than 30 percent of unique patients.(NEW)
▪ NO EXCLUSION
▪ Under proposed 2015 rule objective removed.
5/15/2015 MU 2 & PQRS Seminar 10
3. More than 10 percent of all imaging results, consisting of the image itself and any explanation or other accompanying
information, are accessible through certified EHR technology.(NEW)
▪ EXCLUSION: Any EP who orders fewer than 100 tests that result in an image; or any EP who has no access to electronic imaging results.
▪ Under 2015 proposed rule objective is removed.
4. Record family health history as structure data for more than 20 percent of all unique patients. (NEW)
▪ EXCLUSION: Any EP who has no office visits.
▪ Under 2015 proposed rule objective is removed.
5. Capability to identify and report cancer cases to a public health central cancer registry.(NEW)
▪ EXCLUSION: Any EP who meets at least one of the following criteria may be excluded from this objective: (1) the EP does not diagnose or
directly treat cancer; (2) the EP operates in a jurisdiction where no public health agency is capable of receiving electronic cancer case
information in the standards required for certified EHR technology; (3) the EP operates in a jurisdiction where no such agency provides timely
information on its capability to receive such information; or (4) the EP operates in a jurisdiction where no public health agency that can accept
such information can enroll additional EPs.
▪ Under 2015 proposed rule objective remains, but public health measures have different structure.
6. Capability to identify and report specific cases to a specialized registry other than a cancer registry.(NEW)
▪ EXCLUSON: Any EP who meets at least one of the following criteria may be excluded from this objective: (1) the EP does not diagnose or
directly treat any disease associated with a specialized registry sponsored by a national specialty society for which the EP is eligible, or the
public health agencies in their jurisdiction; (2) the EP operates in a jurisdiction where no specialized registry sponsored by a public health
agency or by an applicable national specialty society is capable of receiving electronic specific case information in the standards required by
certified EHR technology; (3) the EP operates in a jurisdiction where no such agency or applicable national specialty society provides timely
information on capability to receive such information; or (4) the EP operates in a jurisdiction where no such registry can enroll additional EPs.
▪ Under 2015 proposed rule objective remains, but public health measures have different structure.
5/15/2015 MU 2 & PQRS Seminar 11
CPOE
Use computerized provider order entry (CPOE) for medication, laboratory, and radiology orders directly
entered by any licensed healthcare professional who can enter orders into the medical record per state, local,
and professional guidelines
• More than 60 percent of medication, 30 percent of laboratory, and 30 percent of radiology orders created by the EP
during
• the EHR reporting period are recorded using CPOE
5/15/2015 MU 2 & PQRS Seminar 12
Clinical Decision Support
Use clinical decision support to improve performance on high-priority health conditions
Measure 1:
• Implement five clinical decision support interventions related to four or more clinical quality measures at a relevant point in
patient care for the entire EHR reporting period. Absent four clinical quality measures related to an EP’s scope of practice or
patient population, the clinical decision support interventions must be related to high-priority health conditions
Measure 2:
• The EP has enabled and implemented the functionality for drug-drug and drug-allergy interaction checks for the entire EHR
reporting period
5/15/2015 MU 2 & PQRS Seminar 13
5/15/2015 MU 2 & PQRS Seminar 14
Clinical Guidelines
5/15/2015 MU 2 & PQRS Seminar 15
My Plan
5/15/2015 MU 2 & PQRS Seminar 16
Screening Tools
5/15/2015 MU 2 & PQRS Seminar 17
Patient Education
Use clinically relevant information from Certified EHR Technology to identify patient-specific education resources
and provide those resources to the patient
• Patient-specific education resources identified by Certified EHR Technology are provided to patients for more than 10 percent of
all unique patients with office visits seen by the EP during the EHR reporting period
5/15/2015 MU 2 & PQRS Seminar 18
Problem or Diagnosis List
5/15/2015 MU 2 & PQRS Seminar 19
Medication Modular
5/15/2015 MU 2 & PQRS Seminar 20
5/15/2015 MU 2 & PQRS Seminar 21
Health Promotion Plan
5/15/2015 MU 2 & PQRS Seminar 22
Advance Audit Tool
5/15/2015 MU 2 & PQRS Seminar 23
Medication Reconciliation
The EP who receives a patient from another setting of care or provider of care or believes an encounter is
relevant should perform medication reconciliation
• The EP who performs medication reconciliation for more than 50 percent of transitions of care in which the patient is
transitioned into the care of the EP
• All Transition of Care, new patients, designated of an encounter with an existing patients with summary of care record
received or electronic C-CCD
5/15/2015 MU 2 & PQRS Seminar 24
Manual Reconciliation
5/15/2015 MU 2 & PQRS Seminar 25
5/15/2015 MU 2 & PQRS Seminar 26
Electronic Reconciliation
5/15/2015 MU 2 & PQRS Seminar 27
5/15/2015 MU 2 & PQRS Seminar 28
5/15/2015 MU 2 & PQRS Seminar 29
DEMO
5/15/2015 MU 2 & PQRS Seminar 30
Summary of Care Record
The EP who transitions their patient to another setting of care or provider of care or refers their patient to another
provider of care should provide summary care record for each transition of care or referral
Measure 1:
• The EP who transitions or refers their patient to another setting of care or provider of care provides summary of care record for
more than 50 percent of transitions of care and referrals – PHI LOG
• Objective removed under 2015 proposed rule.
Measure 2:
• The EP who transitions or refers their patient to another setting of care or provider of care provides a summary of care record
for more than 10 percent of such transitions and referrals either (a) electronically transmitted using CEHRT to a recipient or (b)
where the recipient receives the summary of care record via exchange facilitated by an organization that is a NwHIN Exchange
participant or in a manner that is consistent with the governance mechanism ONC establishes for the NwHIN
Measure 3:
An EP must satisfy one of the following criteria:
• Conducts one or more successful electronic exchanges of a summary of care document, part of which is counted in “measure
2” (for EPs the measure at §495.6(j)(14)(ii)(B) with a recipient who has EHR technology that was developed/designed by a
different EHR
• Conducts one or more successful tests with the CMS-designated test EHR during the EHR reporting period
• Objective removed under 2015 proposed rule.
5/15/2015 MU 2 & PQRS Seminar 31
PHI LOG
5/15/2015 MU 2 & PQRS Seminar 32
5/15/2015 MU 2 & PQRS Seminar 33
5/15/2015 MU 2 & PQRS Seminar 34
Referral Template
DEMO
5/15/2015 MU 2 & PQRS Seminar 35
2015 Proposed Rule for Meaningful Use
Reporting period modifications:
• 2015 and 2016 all new providers just starting MU may select any 90 consecutive days.
• All returning MU providers may select any 90 consecutive days in 2015 for MU.
• In 2016 all returning MU providers would report for entire year.
• In 2017 all providers (new and returning) would report for entire year.
All providers would report under ‘Modified Stage 2’ unless scheduled for Stage 1 in 2015, scheduled Stage 1
providers may use certain matching Stage 1 objectives. (CPOE, e-Rx)
Modified Stage 2 has 9 Core Objectives.
Menu Objective structure removed.
Stage 1 providers must successfully report on ‘1’ public health objective (unless all exclusions met)
Stage 2 providers must successfully report on ‘2’ public health objectives (unless exclusions met)
5/15/2015 MU 2 & PQRS Seminar 36
2015 Proposed Rule for Meaningful Use
Proposed reporting:
5/15/2015 MU 2 & PQRS Seminar 37
2015 Proposed Rule for Meaningful Use
Redundant, duplicative, topped out objectives (no longer requiring reporting):
5/15/2015 MU 2 & PQRS Seminar 38
Objective Stage
Demographics Stage 1 and 2
Vital Signs Stage 1 and 2
Smoking Status Stage 1 and 2
Clinical Summaries Stage 1 and 2
Lab Test Results Stage 1 and 2
Patient Lists Stage 1 and 2
Patient Reminders Stage 1 and 2
Summary of Care (Any method) Stage 1 and 2
Summary of Care (Test exchange) Stage 2
Electronic Notes Stage 2
Imaging Results Stage 2
Family History Stage 2
2015 Proposed Rule for Meaningful Use
Proposed Core Objectives:
• CPOE (Medication, Labs, Radiology)
▪ Stage 1 may use Stage 1 CPOE and exclude from lab and
radiology orders (2015 only).
• E-prescribing
▪ Stage 1 may use Stage 1 objective (2015 only).
• Clinical Decision Support
▪ Stage 1 may use Stage 1 objective (2015 only).
▪ Drug/Drug, Drug/Allergy (DUR) Checks
• Timely Access
▪ Timely Access Measure #1
 Token 4 business days
▪ Timely Access Measure #2
 Threshold dropped to ‘1’ patient.
 Stage 1 provider may exclude (2015 only)
• Security Risk Analysis
▪ Both stages must address encryption.
5/15/2015 MU 2 & PQRS Seminar 39
Proposed Core Objectives:
• Patient Education
▪ Stage 1 provider may exclude if not planned selection
(2015 only)
• Medication Reconciliation
▪ Stage 1 provider may exclude if not planned selection
(2015 only)
• Summary of Care (Electronic exchange)
▪ Stage 1 provider may exclude (2015 only)
• Secure Messages
▪ Objective changed to self-attestation.
▪ Stage 1 provider may exclude (2015 only)
2015 Proposed Rule for Meaningful Use
Public Health Objectives
• Stage 1 provider must successfully report on ‘1’ objective (unless all exclusions met, 2015 only).
• Stage 2 provider must successfully report on ‘2’ objectives (unless exclusions met and provider has less than 2 options)
5/15/2015 MU 2 & PQRS Seminar 40
Measure Times Measure Can Count
Immunization Registry 1
Syndromic Surveillance 1
Case Reporting (new) 1
Public Health Registry (cancer, etc.) 3
Clinical Data Registry Reporting
(specialty registry)
3
Minimal products necessary to help demonstrate Stage 2
Meaningful Use if using only NextGen solutions:
• NextGen® Ambulatory EHR 5.8
▪ e-Prescribing enabled
▪ NextGen Advanced Audit Utility
NextGen® KBM version 8.3 or higher
NextGen® Health Quality Measures (HQM)
Rosetta Interface Agent
• Immunization registry interface
• Syndromic reporting interface (if Menu Measure 1 selected)
• Cancer Case interface (if Menu Measure 5 selected)
• Specialized Registry interface (if Menu Measure 6 selected)
NextGen® Medical Summary Utility
NextGen® Patient Portal (powered by NextMD®) NextGen® Share
5/15/2015 MU 2 & PQRS Seminar 41
White Pages Manual
Nextgen Website:
https://knowledge.nextgen.com/pe/action/forums/navigateresults
Download each white page
Use program to attach white page into 1 manual such as PDFil
Have a separate manual for CQM from Menu and Cores
5/15/2015 MU 2 & PQRS Seminar 42
The National Quality Strategy (NQS)
In 2015, measures are classified according to the 6 NQS domains based on the NQS’s priorities. PQRS reporting
options typically require an EP or PQRS group practice to report 9 or more measures covering at least 3 NQS
domains, plus additional cross-cutting measures for EPs with billable face-to-face encounters for satisfactory
reporting or participation to avoid the 2017 negative payment adjustment.
The Six NQS Domains:
1. Patient Safety
2. Person and Caregiver-Centered Experience and Outcomes
3. Communication and Care Coordination
4. Effective Clinical Care
5. Community/ Population Health
6. Efficiency and Cost Reduction
5/15/2015 MU 2 & PQRS Seminar 43
PQRS INDIVIDUAL EPs
1. Report on at least 9 measures across at least 3 National Quality Strategy (NQS) domains
2. Use a direct EHR product that is Certified EHR Technology (CEHRT) or EHR data submission
vendor that is CEHRT
• If the EP’s CEHRT does not contain patient data for at least 9 measures across at least 3 domains, then the
EP must report the measures for which there is Medicare patient data. An EP must report on at least 1
measure containing Medicare patient data.
Note for EHR Incentive Program participants: If an EP satisfactorily reports for 2015 PQRS using
the electronic reporting option, (s)he will also satisfy the CQM component of the EHR Incentive
program; however, EPs will still be required to meet the other Meaningful Use objectives through
the Medicare EHR Incentive Program Registration and Attestation System.
5/15/2015 MU 2 & PQRS Seminar 44
2013 0.5% (performance year for 2015 penalty)
2014
0.5% (performance year for 2016 penalty)
2015 -1.5%
2016 -2%
2017 -2%
Medicare Physician Quality Reporting System
Incentives and Penalties
5/15/2015 MU 2 & PQRS Seminar 45
46
Reference
http://www.ama-assn.org/ama/pub/physician-resources/clinical-practice-improvement/clinical-
quality/physician-quality-reporting-system.page?
2015 Physician Quality Reporting System (PQRS): Implementation Guide 1/15/2015 , CMS
Stage 1 vs. Stage 2 Comparison Table for Eligible Professionals , CMS
MU Core and menu objectives Manual, Nextgen
Nextgen E-Learning
5/15/2015 MU 2 & PQRS Seminar 47

More Related Content

What's hot

Presentation Trends in Australian and international regulation and regulatory...
Presentation Trends in Australian and international regulation and regulatory...Presentation Trends in Australian and international regulation and regulatory...
Presentation Trends in Australian and international regulation and regulatory...TGA Australia
 
Presentation: The role of the patient in pharmacovigilance
Presentation: The role of the patient in pharmacovigilancePresentation: The role of the patient in pharmacovigilance
Presentation: The role of the patient in pharmacovigilanceTGA Australia
 
pharmacovigilance in india-by dr.nagaraja prasad.s
pharmacovigilance in india-by dr.nagaraja prasad.spharmacovigilance in india-by dr.nagaraja prasad.s
pharmacovigilance in india-by dr.nagaraja prasad.sNagaraja Prasad Sai
 
Expert review of medicines and medical devices regulation: Prescription medic...
Expert review of medicines and medical devices regulation: Prescription medic...Expert review of medicines and medical devices regulation: Prescription medic...
Expert review of medicines and medical devices regulation: Prescription medic...TGA Australia
 
Presentation: Clinical Evidence Guidelines
Presentation: Clinical Evidence GuidelinesPresentation: Clinical Evidence Guidelines
Presentation: Clinical Evidence GuidelinesTGA Australia
 
Presentation: Prescription Medicines Reforms
Presentation: Prescription Medicines ReformsPresentation: Prescription Medicines Reforms
Presentation: Prescription Medicines ReformsTGA Australia
 
The TGA Pharmacovigilance Inspection Pilot Program: 2015-2016
The TGA Pharmacovigilance Inspection Pilot Program: 2015-2016The TGA Pharmacovigilance Inspection Pilot Program: 2015-2016
The TGA Pharmacovigilance Inspection Pilot Program: 2015-2016TGA Australia
 
Spotlight on MMDR Further Reviews and Advertising Reforms
Spotlight on MMDR Further Reviews and Advertising ReformsSpotlight on MMDR Further Reviews and Advertising Reforms
Spotlight on MMDR Further Reviews and Advertising ReformsTGA Australia
 
Presentation: Proposed Reforms to the Regulation of Software, Including Softw...
Presentation: Proposed Reforms to the Regulation of Software, Including Softw...Presentation: Proposed Reforms to the Regulation of Software, Including Softw...
Presentation: Proposed Reforms to the Regulation of Software, Including Softw...TGA Australia
 
Presentation: A spotlight on other reforms from the medicines and medical dev...
Presentation: A spotlight on other reforms from the medicines and medical dev...Presentation: A spotlight on other reforms from the medicines and medical dev...
Presentation: A spotlight on other reforms from the medicines and medical dev...TGA Australia
 
Presentation: Increasing post-market vigilance requirements for medical devices
Presentation: Increasing post-market vigilance requirements for medical devicesPresentation: Increasing post-market vigilance requirements for medical devices
Presentation: Increasing post-market vigilance requirements for medical devicesTGA Australia
 
Pharmacovigilance organisation
Pharmacovigilance organisationPharmacovigilance organisation
Pharmacovigilance organisationSomya Solanki
 
Are You Ready for Stage 2 Meaningful Use?
Are You Ready for Stage 2 Meaningful Use?Are You Ready for Stage 2 Meaningful Use?
Are You Ready for Stage 2 Meaningful Use?MUforBH
 
TGA Presentation: Legislative framework and Commonwealth access schemes relev...
TGA Presentation: Legislative framework and Commonwealth access schemes relev...TGA Presentation: Legislative framework and Commonwealth access schemes relev...
TGA Presentation: Legislative framework and Commonwealth access schemes relev...TGA Australia
 
Presentation: What's trending in medicines regulation? A January 2017 reflection
Presentation: What's trending in medicines regulation? A January 2017 reflectionPresentation: What's trending in medicines regulation? A January 2017 reflection
Presentation: What's trending in medicines regulation? A January 2017 reflectionTGA Australia
 
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...TGA Australia
 
Presentation: Risk minimisation in the Australian context
Presentation: Risk minimisation in the Australian contextPresentation: Risk minimisation in the Australian context
Presentation: Risk minimisation in the Australian contextTGA Australia
 
Webinar 4 : Achieve Meaningful Use Core Measures & Menu Measures using DigiDM...
Webinar 4 : Achieve Meaningful Use Core Measures & Menu Measures using DigiDM...Webinar 4 : Achieve Meaningful Use Core Measures & Menu Measures using DigiDM...
Webinar 4 : Achieve Meaningful Use Core Measures & Menu Measures using DigiDM...Sagar Shah
 
PVPI _ A Cost Effective Programme For Patients
PVPI _ A Cost Effective Programme For Patients PVPI _ A Cost Effective Programme For Patients
PVPI _ A Cost Effective Programme For Patients Nani Karnam Vinayakam
 

What's hot (20)

Presentation Trends in Australian and international regulation and regulatory...
Presentation Trends in Australian and international regulation and regulatory...Presentation Trends in Australian and international regulation and regulatory...
Presentation Trends in Australian and international regulation and regulatory...
 
Presentation: The role of the patient in pharmacovigilance
Presentation: The role of the patient in pharmacovigilancePresentation: The role of the patient in pharmacovigilance
Presentation: The role of the patient in pharmacovigilance
 
pharmacovigilance in india-by dr.nagaraja prasad.s
pharmacovigilance in india-by dr.nagaraja prasad.spharmacovigilance in india-by dr.nagaraja prasad.s
pharmacovigilance in india-by dr.nagaraja prasad.s
 
Expert review of medicines and medical devices regulation: Prescription medic...
Expert review of medicines and medical devices regulation: Prescription medic...Expert review of medicines and medical devices regulation: Prescription medic...
Expert review of medicines and medical devices regulation: Prescription medic...
 
Presentation: Clinical Evidence Guidelines
Presentation: Clinical Evidence GuidelinesPresentation: Clinical Evidence Guidelines
Presentation: Clinical Evidence Guidelines
 
Presentation: Prescription Medicines Reforms
Presentation: Prescription Medicines ReformsPresentation: Prescription Medicines Reforms
Presentation: Prescription Medicines Reforms
 
The TGA Pharmacovigilance Inspection Pilot Program: 2015-2016
The TGA Pharmacovigilance Inspection Pilot Program: 2015-2016The TGA Pharmacovigilance Inspection Pilot Program: 2015-2016
The TGA Pharmacovigilance Inspection Pilot Program: 2015-2016
 
Spotlight on MMDR Further Reviews and Advertising Reforms
Spotlight on MMDR Further Reviews and Advertising ReformsSpotlight on MMDR Further Reviews and Advertising Reforms
Spotlight on MMDR Further Reviews and Advertising Reforms
 
Presentation: Proposed Reforms to the Regulation of Software, Including Softw...
Presentation: Proposed Reforms to the Regulation of Software, Including Softw...Presentation: Proposed Reforms to the Regulation of Software, Including Softw...
Presentation: Proposed Reforms to the Regulation of Software, Including Softw...
 
Presentation: A spotlight on other reforms from the medicines and medical dev...
Presentation: A spotlight on other reforms from the medicines and medical dev...Presentation: A spotlight on other reforms from the medicines and medical dev...
Presentation: A spotlight on other reforms from the medicines and medical dev...
 
Presentation: Increasing post-market vigilance requirements for medical devices
Presentation: Increasing post-market vigilance requirements for medical devicesPresentation: Increasing post-market vigilance requirements for medical devices
Presentation: Increasing post-market vigilance requirements for medical devices
 
Pharmacovigilance organisation
Pharmacovigilance organisationPharmacovigilance organisation
Pharmacovigilance organisation
 
Are You Ready for Stage 2 Meaningful Use?
Are You Ready for Stage 2 Meaningful Use?Are You Ready for Stage 2 Meaningful Use?
Are You Ready for Stage 2 Meaningful Use?
 
Haemovigilance
HaemovigilanceHaemovigilance
Haemovigilance
 
TGA Presentation: Legislative framework and Commonwealth access schemes relev...
TGA Presentation: Legislative framework and Commonwealth access schemes relev...TGA Presentation: Legislative framework and Commonwealth access schemes relev...
TGA Presentation: Legislative framework and Commonwealth access schemes relev...
 
Presentation: What's trending in medicines regulation? A January 2017 reflection
Presentation: What's trending in medicines regulation? A January 2017 reflectionPresentation: What's trending in medicines regulation? A January 2017 reflection
Presentation: What's trending in medicines regulation? A January 2017 reflection
 
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
 
Presentation: Risk minimisation in the Australian context
Presentation: Risk minimisation in the Australian contextPresentation: Risk minimisation in the Australian context
Presentation: Risk minimisation in the Australian context
 
Webinar 4 : Achieve Meaningful Use Core Measures & Menu Measures using DigiDM...
Webinar 4 : Achieve Meaningful Use Core Measures & Menu Measures using DigiDM...Webinar 4 : Achieve Meaningful Use Core Measures & Menu Measures using DigiDM...
Webinar 4 : Achieve Meaningful Use Core Measures & Menu Measures using DigiDM...
 
PVPI _ A Cost Effective Programme For Patients
PVPI _ A Cost Effective Programme For Patients PVPI _ A Cost Effective Programme For Patients
PVPI _ A Cost Effective Programme For Patients
 

Similar to MU - PQRS presentation

Modifed Stage 2 2015
Modifed Stage 2 2015Modifed Stage 2 2015
Modifed Stage 2 2015Melisa Pierce
 
How to get Prepared and Find Success with Meaningful Use Stage 2 and 3
How to get Prepared and Find Success with Meaningful Use Stage 2 and 3How to get Prepared and Find Success with Meaningful Use Stage 2 and 3
How to get Prepared and Find Success with Meaningful Use Stage 2 and 3Iatric Systems
 
Get Prepared and Find Success with Meaningful Use Stage 2 and 3
Get Prepared and Find Success with Meaningful Use Stage 2 and 3Get Prepared and Find Success with Meaningful Use Stage 2 and 3
Get Prepared and Find Success with Meaningful Use Stage 2 and 3Iatric Systems
 
Meaningful use stage 2 - Final Rule
Meaningful use stage 2 - Final RuleMeaningful use stage 2 - Final Rule
Meaningful use stage 2 - Final RuleZH Healthcare
 
Meaningful Use Updates Webinar Slidedeck
Meaningful Use Updates Webinar SlidedeckMeaningful Use Updates Webinar Slidedeck
Meaningful Use Updates Webinar SlidedeckKimberly Hilton
 
Meaningful Use Overview 2016 pp
Meaningful Use Overview 2016 ppMeaningful Use Overview 2016 pp
Meaningful Use Overview 2016 ppApril Lowry
 
Updated Meaningful Use and Attestation Webinar
Updated Meaningful Use and Attestation WebinarUpdated Meaningful Use and Attestation Webinar
Updated Meaningful Use and Attestation WebinarKimberly Hilton
 
Meaningful Use in 2014
Meaningful Use in 2014Meaningful Use in 2014
Meaningful Use in 2014Ben Quirk
 
Meaningful Use Final Rule Updates 2015
Meaningful Use Final Rule Updates 2015Meaningful Use Final Rule Updates 2015
Meaningful Use Final Rule Updates 2015Ben Quirk
 
Meaningful Use Stage 2 Kickoff
Meaningful Use Stage 2 KickoffMeaningful Use Stage 2 Kickoff
Meaningful Use Stage 2 KickoffPractice Fusion
 
Meaningful Use Workgroup Recommendations
Meaningful Use Workgroup Recommendations Meaningful Use Workgroup Recommendations
Meaningful Use Workgroup Recommendations Brian Ahier
 
Health IT Summit Austin 2013 - Keynote Presentation "Meaningful Use Stage 2 a...
Health IT Summit Austin 2013 - Keynote Presentation "Meaningful Use Stage 2 a...Health IT Summit Austin 2013 - Keynote Presentation "Meaningful Use Stage 2 a...
Health IT Summit Austin 2013 - Keynote Presentation "Meaningful Use Stage 2 a...Health IT Conference – iHT2
 
Meaningful Use in 2015: 6 things to do before the year’s end
Meaningful Use in 2015: 6 things to do before the year’s endMeaningful Use in 2015: 6 things to do before the year’s end
Meaningful Use in 2015: 6 things to do before the year’s endCureMD
 
Meaningful use Stage 2 Webinar
Meaningful use Stage 2 WebinarMeaningful use Stage 2 Webinar
Meaningful use Stage 2 WebinarPractice Fusion
 
Insights2020 cpt changes
Insights2020 cpt changesInsights2020 cpt changes
Insights2020 cpt changesBen Quirk
 
Meaningful Use: Programs, Penalities, and Payments
Meaningful Use: Programs, Penalities, and PaymentsMeaningful Use: Programs, Penalities, and Payments
Meaningful Use: Programs, Penalities, and PaymentsBen Quirk
 
CMS Meaningful Use rule announcement 7-13-2010
CMS Meaningful Use rule announcement 7-13-2010CMS Meaningful Use rule announcement 7-13-2010
CMS Meaningful Use rule announcement 7-13-2010e-Patient Dave deBronkart
 
Expanded Meaningful Use
Expanded Meaningful UseExpanded Meaningful Use
Expanded Meaningful UseBen Quirk
 
Preparing for Meaningful Use Stage 2 and ICD 10
Preparing for Meaningful Use Stage 2 and ICD 10Preparing for Meaningful Use Stage 2 and ICD 10
Preparing for Meaningful Use Stage 2 and ICD 10Eileen Seagraves
 

Similar to MU - PQRS presentation (20)

Modifed Stage 2 2015
Modifed Stage 2 2015Modifed Stage 2 2015
Modifed Stage 2 2015
 
How to get Prepared and Find Success with Meaningful Use Stage 2 and 3
How to get Prepared and Find Success with Meaningful Use Stage 2 and 3How to get Prepared and Find Success with Meaningful Use Stage 2 and 3
How to get Prepared and Find Success with Meaningful Use Stage 2 and 3
 
Get Prepared and Find Success with Meaningful Use Stage 2 and 3
Get Prepared and Find Success with Meaningful Use Stage 2 and 3Get Prepared and Find Success with Meaningful Use Stage 2 and 3
Get Prepared and Find Success with Meaningful Use Stage 2 and 3
 
Meaningful use stage 2 - Final Rule
Meaningful use stage 2 - Final RuleMeaningful use stage 2 - Final Rule
Meaningful use stage 2 - Final Rule
 
Meaningful Use Updates Webinar Slidedeck
Meaningful Use Updates Webinar SlidedeckMeaningful Use Updates Webinar Slidedeck
Meaningful Use Updates Webinar Slidedeck
 
Meaningful Use Overview 2016 pp
Meaningful Use Overview 2016 ppMeaningful Use Overview 2016 pp
Meaningful Use Overview 2016 pp
 
Updated Meaningful Use and Attestation Webinar
Updated Meaningful Use and Attestation WebinarUpdated Meaningful Use and Attestation Webinar
Updated Meaningful Use and Attestation Webinar
 
Meaningful Use in 2014
Meaningful Use in 2014Meaningful Use in 2014
Meaningful Use in 2014
 
Meaningful Use Final Rule Updates 2015
Meaningful Use Final Rule Updates 2015Meaningful Use Final Rule Updates 2015
Meaningful Use Final Rule Updates 2015
 
Meaningful Use Stage 2 Kickoff
Meaningful Use Stage 2 KickoffMeaningful Use Stage 2 Kickoff
Meaningful Use Stage 2 Kickoff
 
Meaningful Use Workgroup Recommendations
Meaningful Use Workgroup Recommendations Meaningful Use Workgroup Recommendations
Meaningful Use Workgroup Recommendations
 
Health IT Summit Austin 2013 - Keynote Presentation "Meaningful Use Stage 2 a...
Health IT Summit Austin 2013 - Keynote Presentation "Meaningful Use Stage 2 a...Health IT Summit Austin 2013 - Keynote Presentation "Meaningful Use Stage 2 a...
Health IT Summit Austin 2013 - Keynote Presentation "Meaningful Use Stage 2 a...
 
Meaningful Use in 2015: 6 things to do before the year’s end
Meaningful Use in 2015: 6 things to do before the year’s endMeaningful Use in 2015: 6 things to do before the year’s end
Meaningful Use in 2015: 6 things to do before the year’s end
 
Meaningful Use Mini-Camp Presentation
Meaningful Use Mini-Camp PresentationMeaningful Use Mini-Camp Presentation
Meaningful Use Mini-Camp Presentation
 
Meaningful use Stage 2 Webinar
Meaningful use Stage 2 WebinarMeaningful use Stage 2 Webinar
Meaningful use Stage 2 Webinar
 
Insights2020 cpt changes
Insights2020 cpt changesInsights2020 cpt changes
Insights2020 cpt changes
 
Meaningful Use: Programs, Penalities, and Payments
Meaningful Use: Programs, Penalities, and PaymentsMeaningful Use: Programs, Penalities, and Payments
Meaningful Use: Programs, Penalities, and Payments
 
CMS Meaningful Use rule announcement 7-13-2010
CMS Meaningful Use rule announcement 7-13-2010CMS Meaningful Use rule announcement 7-13-2010
CMS Meaningful Use rule announcement 7-13-2010
 
Expanded Meaningful Use
Expanded Meaningful UseExpanded Meaningful Use
Expanded Meaningful Use
 
Preparing for Meaningful Use Stage 2 and ICD 10
Preparing for Meaningful Use Stage 2 and ICD 10Preparing for Meaningful Use Stage 2 and ICD 10
Preparing for Meaningful Use Stage 2 and ICD 10
 

MU - PQRS presentation

  • 1. THE KEY TO MEANINGFUL USE STAGE 2 & PQRS PRESENTER: MARCIA FASTAG, MA, OTR/L, CMUP Professional Services Consultant
  • 2. Agenda MU Core and Menu Measures with key changes between stages 1 and 2 including exemptions. • Proposed MU Changes • Special emphasis will be placed on the following changes: ▪ CPOE ▪ Clinical Decision Support ▪ Patient Education ▪ Medication Reconciliation ▪ Summary of Care ▪ Transition of Care PQRSCQM Crosswalk 5/15/2015 MU 2 & PQRS Seminar 2
  • 3. MU Core Measures Stage 2 vs Stage 1 With Exclusions EPs must satisfy the requirements of all 17 core objectives to meet Stage 2 of Meaningful Use. The core objectives follow: 1. Use Computerized Provider Order Entry (CPOE) for more than 60 percent of medication, 30 percent of laboratory tests, and 30 percent of radiology orders directly entered into the medical record. – STAGE 1 MEDICATION 30% ▪ EXCLUSION - CPOE for Medication, Laboratory, and Radiology Orders: Any EP who writes fewer than 100 medication, radiology, or laboratory orders. ▪ Under proposed 2015 rule Stage 1 providers could claim exclusion for lab/radiology and select Stage 1 CPOE for medication orders 2. More than 50% of all permissible prescriptions written by the EP are compared to at least one drug formulary STAGE 1 – 40% ▪ EXCLUSION – Prescribe less than 100 prescriptions during the recording period. ▪ Under proposed 2015 rule Stage 1 providers may report on Stage 1 objective 5/15/2015 MU 2 & PQRS Seminar 3
  • 4. MU Core Measures Stage 2 vs Stage 1 With Exclusions EPs must satisfy the requirements of all 17 core objectives to meet Stage 2 of Meaningful Use. The core objectives follow: 3. Record demographics for more than 80 percent of all unique patients, including preferred language, sex, race, ethnicity, date of birth. STAGE 1 50% ▪ NO EXCLUSION ▪ Under proposed 2015 rule providers would not have to report numerator/denominator. 4. Record and chart changes in vital signs for more than 80 percent of all unique patients, including height/length and weight (no age limit); blood pressure (ages 3 and over); calculate and display Body Mass Index (BMI); and plot and display growth charts for patients 0 to 20 years of age, including BMI. STAGE 1 40% ▪ EXCEMPTION: Record Vital Signs: Any EP who (1) sees no patients 3 years of age or older is excluded from recording blood pressure; (2) believes that all three vital signs of height/length, weight, and blood pressure have no relevance to their scope of practice is excluded from recording them; (3) believes that blood pressure alone is not relevant to the scope of practice is excluded from recording it; (4) believes that height/length and weight alone are not relevant to the scope of the practice is excluded from recording them. ▪ Under proposed 2015 rule providers would not have to report numerator/denominator. 5/15/2015 MU 2 & PQRS Seminar 4
  • 5. 5. Record smoking status for more than 80 percent of patients 13 years of age or older. STAGE 1 50% ▪ EXCLUSION: Any EP who neither sees nor admits any patients 13 years of age or older. ▪ Under proposed 2015 rule providers would not have to report numerator/denominator. 6. Use Clinical Decision Support (CDS) to improve performance on high-priority health conditions. Implement five CDS interventions related to four or more clinical quality measures and enable the functionality for drug-drug and drug-allergy interaction checks. STAGE 1 one measure ▪ Under proposed 2015 rule Stage 1 providers may report on current Stage 1 objective. 7. Provide more than 50 percent of all unique patients the ability to view online, download, and transmit their health information within four business days of the information being available to the EP. More than 5 percent of all unique patients must view, download, or transmit their health information to a third party. STAGE 1 More than 50% of all patients of the EP who request an electronic copy of their health information are provided it within 3 business days ▪ EXCLUSION: Patient Electronic Access: Any EP who (1) neither orders nor creates any of the information listed for inclusion as part of both measures—except for patient name, provider name, and office contact information—may exclude both measures; (2) conducts 50 percent or more of patient encounters in a county where fewer than 50 percent of housing units have 3 Mbps broadband availability according to the FCC may exclude only the second measure ▪ Measure #1 unchanged under 2015 proposed rule. ▪ Measure #2 threshold previously more than 5 percent proposed to change to ‘1’ patient. 5/15/2015 MU 2 & PQRS Seminar 5
  • 6. 8. Provide clinical summaries to patients for more than 50 percent of office visits within one business day. STAGE 1 – 3 days ▪ EXCLUSION: Clinical Summaries: Any EP who has no office visits. ▪ Under proposed 2015 rule providers would not have to report numerator/denominator. 9. Protect electronic health information created or maintained by the certified EHR technology through the implementation of appropriate technical capabilities by conducting or reviewing a security risk analysis in accordance with the requirements under 45 C.F.R. § 164.308 (a)(1). ▪ NO EXCLUSION ▪ Under proposed rule both Stage 1 and Stage 2 providers will need to address encryption. • Microsoft 10 PRO includes device and file encryption via BitLocker, along with many other security enhancements • Hardware-based encryption allows for improved performance, because a dedicated processor encrypts all data that is written to the hard disk • business smartphones that have a work / personal partition • MS Office 365 (Outlook) can be used for end-to-end encryption, for $2/user/month, with Azure Rights Management • For practices that need HIPAA-compliant file sharing, Sookasais affordable and convenient • For practices that want to text PHI, TigerText is affordable and convenient 10. Incorporate more than 55 percent of all clinical lab-test results into certified EHR technology as structured data. STAGE 1 40% ▪ EXCLUSION: Any EP who orders no lab tests where results are either in a positive/negative affirmation or numeric format. ▪ Under proposed 2015 rule providers would not have to report numerator/denominator. 5/15/2015 MU 2 & PQRS Seminar 6
  • 7. 11. Generate lists of patients by specific conditions to use for quality improvement, reduction of disparities, research, or outreach. ▪ NO EXCLUSIONS ▪ Under proposed 2015 rule objective is removed. 12. Use EHR to identify and provide reminders for preventive/follow-up care for more than 10% of patients with two or more office visits in the last 2 years STAGE 1 - More than 20% of all unique patients 65 years or older or 5 years old or younger were sent an appropriate reminder during the EHR reporting period ▪ EXCLUSION: Any EP who has had no office visits in the previous 24 months ▪ Under proposed 2015 rule providers would not have to report numerator/denominator. 13. Patient-specific education resources identified by CEHRT are provided to patients for more than 10% of all unique patients with office visits seen by the EP during the EHR reporting period. ▪ EXCLUSION: Any EP who has had no office visits ▪ Under proposed 2015 rule a Stage 1 provider may claim exclusion if education was not a planned menu objective. 5/15/2015 MU 2 & PQRS Seminar 7
  • 8. 14. The EP who receives a patient from another setting of care or provider of care, or who believes an encounter is relevant, should perform medication reconciliation for more than 50 percent of patients. ▪ EXCLUSION: Any EP who was not the recipient of any transitions of care ▪ Under proposed 2015 rule a Stage 1 provider may claim exclusion if reconciliation was not a planned menu objective. 15. The EP who transitions their patient to another setting of care or provider of care or refers their patient to another provider of care should provide summary of care record for each transition of care or referral 1. The EP who transitions or refers their patient to another setting of care or provider of care provides a summary of care record for more than 50% of transitions of care and referrals ▪ Under proposed 2015 rule objective is removed. 2. The EP who transitions or refers their patient to another setting of care or provider of care provides a summary of care record either a) electronically transmitted to a recipient using CEHRT or b) where the recipient receives the summary of care record via exchange facilitated by an organization that is a NwHIN Exchange participant or is validated through an ONC-established governance mechanism to facilitate exchange for 10% of transitions and referrals ▪ Under proposed 2015 rule Stage 1 providers may claim exclusion. 3. The EP who transitions or refers their patient to another setting of care or provider of care must either a) conduct one or more successful electronic exchanges of a summary of care record with a recipient using technology that was designed by a different EHR developer than the sender's, or b) conduct one or more successful tests with the CMS-designated test EHR during the EHR reporting period ▪ EXCLUSION: Any EP who transfers a patient to another setting or refers a patient to another provider less than 100 times is excluded from all three measures. ▪ Under proposed 2015 rule objective is removed. 5/15/2015 MU 2 & PQRS Seminar 8
  • 9. 16. Capability to submit electronic data to immunization registries or Immunization Information Systems and actual submission except where prohibited and in accordance with applicable law and practice ▪ EXCLUSION: Any EP who meets one or more of the following criteria may be excluded from this objective: (1) the EP does not administer immunizations to any of the populations for which data is collected in their jurisdiction; (2) the EP operates in a jurisdiction where no immunization registry is capable of accepting the data in the specific standards required for certification of the EHR; (3) the EP operates in a jurisdiction where no immunization registry provides timely information on capability to receive immunization data; or (4) the EP operates in a jurisdiction where no immunization registry can enroll additional EPs. ▪ Under 2015 proposed rule objective remains. 17. Use secure electronic messaging to communicate with more than 5 percent of unique patients on relevant health information. (NEW) ▪ EXCLUSION: Any EP who has no office visits, or who conducts 50 percent or more of patient encounters in a county where fewer than 50 percent of housing units have 3 Mbps broadband availability according to the FCC. ▪ Under proposed 2015 rule objective changed to self-attestation and minimum threshold removed. 5/15/2015 MU 2 & PQRS Seminar 9
  • 10. EPs must meet 3 out of 6 of the menu objectives to demonstrate Stage 2 of Meaningful Use. All menu objectives must be achieved in accordance with applicable law and practice. The menu objectives follow: 1. Capability to submit electronic syndromic surveillance data to public health agencies. (Same) ▪ EXCLUSION: Any EP that meets one or more of the following criteria may be excluded from this objective: (1) the EP is not in a category of providers that collect ambulatory syndromic surveillance information on their patients; (2) the EP operates in a jurisdiction where no public health agency is capable of receiving such data in the standards required by certified EHR technology; (3) the EP operates in a jurisdiction where no public health agency provides timely information on capability to receive such data; or (4) the EP operates in a jurisdiction where no public health agency that can accept such data can enroll additional EPs. ▪ Under 2015 proposed rule objective remains. 2. Record at least one electronic progress note in patient records for more than 30 percent of unique patients.(NEW) ▪ NO EXCLUSION ▪ Under proposed 2015 rule objective removed. 5/15/2015 MU 2 & PQRS Seminar 10
  • 11. 3. More than 10 percent of all imaging results, consisting of the image itself and any explanation or other accompanying information, are accessible through certified EHR technology.(NEW) ▪ EXCLUSION: Any EP who orders fewer than 100 tests that result in an image; or any EP who has no access to electronic imaging results. ▪ Under 2015 proposed rule objective is removed. 4. Record family health history as structure data for more than 20 percent of all unique patients. (NEW) ▪ EXCLUSION: Any EP who has no office visits. ▪ Under 2015 proposed rule objective is removed. 5. Capability to identify and report cancer cases to a public health central cancer registry.(NEW) ▪ EXCLUSION: Any EP who meets at least one of the following criteria may be excluded from this objective: (1) the EP does not diagnose or directly treat cancer; (2) the EP operates in a jurisdiction where no public health agency is capable of receiving electronic cancer case information in the standards required for certified EHR technology; (3) the EP operates in a jurisdiction where no such agency provides timely information on its capability to receive such information; or (4) the EP operates in a jurisdiction where no public health agency that can accept such information can enroll additional EPs. ▪ Under 2015 proposed rule objective remains, but public health measures have different structure. 6. Capability to identify and report specific cases to a specialized registry other than a cancer registry.(NEW) ▪ EXCLUSON: Any EP who meets at least one of the following criteria may be excluded from this objective: (1) the EP does not diagnose or directly treat any disease associated with a specialized registry sponsored by a national specialty society for which the EP is eligible, or the public health agencies in their jurisdiction; (2) the EP operates in a jurisdiction where no specialized registry sponsored by a public health agency or by an applicable national specialty society is capable of receiving electronic specific case information in the standards required by certified EHR technology; (3) the EP operates in a jurisdiction where no such agency or applicable national specialty society provides timely information on capability to receive such information; or (4) the EP operates in a jurisdiction where no such registry can enroll additional EPs. ▪ Under 2015 proposed rule objective remains, but public health measures have different structure. 5/15/2015 MU 2 & PQRS Seminar 11
  • 12. CPOE Use computerized provider order entry (CPOE) for medication, laboratory, and radiology orders directly entered by any licensed healthcare professional who can enter orders into the medical record per state, local, and professional guidelines • More than 60 percent of medication, 30 percent of laboratory, and 30 percent of radiology orders created by the EP during • the EHR reporting period are recorded using CPOE 5/15/2015 MU 2 & PQRS Seminar 12
  • 13. Clinical Decision Support Use clinical decision support to improve performance on high-priority health conditions Measure 1: • Implement five clinical decision support interventions related to four or more clinical quality measures at a relevant point in patient care for the entire EHR reporting period. Absent four clinical quality measures related to an EP’s scope of practice or patient population, the clinical decision support interventions must be related to high-priority health conditions Measure 2: • The EP has enabled and implemented the functionality for drug-drug and drug-allergy interaction checks for the entire EHR reporting period 5/15/2015 MU 2 & PQRS Seminar 13
  • 14. 5/15/2015 MU 2 & PQRS Seminar 14
  • 15. Clinical Guidelines 5/15/2015 MU 2 & PQRS Seminar 15
  • 16. My Plan 5/15/2015 MU 2 & PQRS Seminar 16
  • 17. Screening Tools 5/15/2015 MU 2 & PQRS Seminar 17
  • 18. Patient Education Use clinically relevant information from Certified EHR Technology to identify patient-specific education resources and provide those resources to the patient • Patient-specific education resources identified by Certified EHR Technology are provided to patients for more than 10 percent of all unique patients with office visits seen by the EP during the EHR reporting period 5/15/2015 MU 2 & PQRS Seminar 18
  • 19. Problem or Diagnosis List 5/15/2015 MU 2 & PQRS Seminar 19
  • 20. Medication Modular 5/15/2015 MU 2 & PQRS Seminar 20
  • 21. 5/15/2015 MU 2 & PQRS Seminar 21
  • 22. Health Promotion Plan 5/15/2015 MU 2 & PQRS Seminar 22
  • 23. Advance Audit Tool 5/15/2015 MU 2 & PQRS Seminar 23
  • 24. Medication Reconciliation The EP who receives a patient from another setting of care or provider of care or believes an encounter is relevant should perform medication reconciliation • The EP who performs medication reconciliation for more than 50 percent of transitions of care in which the patient is transitioned into the care of the EP • All Transition of Care, new patients, designated of an encounter with an existing patients with summary of care record received or electronic C-CCD 5/15/2015 MU 2 & PQRS Seminar 24
  • 25. Manual Reconciliation 5/15/2015 MU 2 & PQRS Seminar 25
  • 26. 5/15/2015 MU 2 & PQRS Seminar 26
  • 28. 5/15/2015 MU 2 & PQRS Seminar 28
  • 29. 5/15/2015 MU 2 & PQRS Seminar 29
  • 30. DEMO 5/15/2015 MU 2 & PQRS Seminar 30
  • 31. Summary of Care Record The EP who transitions their patient to another setting of care or provider of care or refers their patient to another provider of care should provide summary care record for each transition of care or referral Measure 1: • The EP who transitions or refers their patient to another setting of care or provider of care provides summary of care record for more than 50 percent of transitions of care and referrals – PHI LOG • Objective removed under 2015 proposed rule. Measure 2: • The EP who transitions or refers their patient to another setting of care or provider of care provides a summary of care record for more than 10 percent of such transitions and referrals either (a) electronically transmitted using CEHRT to a recipient or (b) where the recipient receives the summary of care record via exchange facilitated by an organization that is a NwHIN Exchange participant or in a manner that is consistent with the governance mechanism ONC establishes for the NwHIN Measure 3: An EP must satisfy one of the following criteria: • Conducts one or more successful electronic exchanges of a summary of care document, part of which is counted in “measure 2” (for EPs the measure at §495.6(j)(14)(ii)(B) with a recipient who has EHR technology that was developed/designed by a different EHR • Conducts one or more successful tests with the CMS-designated test EHR during the EHR reporting period • Objective removed under 2015 proposed rule. 5/15/2015 MU 2 & PQRS Seminar 31
  • 32. PHI LOG 5/15/2015 MU 2 & PQRS Seminar 32
  • 33. 5/15/2015 MU 2 & PQRS Seminar 33
  • 34. 5/15/2015 MU 2 & PQRS Seminar 34 Referral Template
  • 35. DEMO 5/15/2015 MU 2 & PQRS Seminar 35
  • 36. 2015 Proposed Rule for Meaningful Use Reporting period modifications: • 2015 and 2016 all new providers just starting MU may select any 90 consecutive days. • All returning MU providers may select any 90 consecutive days in 2015 for MU. • In 2016 all returning MU providers would report for entire year. • In 2017 all providers (new and returning) would report for entire year. All providers would report under ‘Modified Stage 2’ unless scheduled for Stage 1 in 2015, scheduled Stage 1 providers may use certain matching Stage 1 objectives. (CPOE, e-Rx) Modified Stage 2 has 9 Core Objectives. Menu Objective structure removed. Stage 1 providers must successfully report on ‘1’ public health objective (unless all exclusions met) Stage 2 providers must successfully report on ‘2’ public health objectives (unless exclusions met) 5/15/2015 MU 2 & PQRS Seminar 36
  • 37. 2015 Proposed Rule for Meaningful Use Proposed reporting: 5/15/2015 MU 2 & PQRS Seminar 37
  • 38. 2015 Proposed Rule for Meaningful Use Redundant, duplicative, topped out objectives (no longer requiring reporting): 5/15/2015 MU 2 & PQRS Seminar 38 Objective Stage Demographics Stage 1 and 2 Vital Signs Stage 1 and 2 Smoking Status Stage 1 and 2 Clinical Summaries Stage 1 and 2 Lab Test Results Stage 1 and 2 Patient Lists Stage 1 and 2 Patient Reminders Stage 1 and 2 Summary of Care (Any method) Stage 1 and 2 Summary of Care (Test exchange) Stage 2 Electronic Notes Stage 2 Imaging Results Stage 2 Family History Stage 2
  • 39. 2015 Proposed Rule for Meaningful Use Proposed Core Objectives: • CPOE (Medication, Labs, Radiology) ▪ Stage 1 may use Stage 1 CPOE and exclude from lab and radiology orders (2015 only). • E-prescribing ▪ Stage 1 may use Stage 1 objective (2015 only). • Clinical Decision Support ▪ Stage 1 may use Stage 1 objective (2015 only). ▪ Drug/Drug, Drug/Allergy (DUR) Checks • Timely Access ▪ Timely Access Measure #1  Token 4 business days ▪ Timely Access Measure #2  Threshold dropped to ‘1’ patient.  Stage 1 provider may exclude (2015 only) • Security Risk Analysis ▪ Both stages must address encryption. 5/15/2015 MU 2 & PQRS Seminar 39 Proposed Core Objectives: • Patient Education ▪ Stage 1 provider may exclude if not planned selection (2015 only) • Medication Reconciliation ▪ Stage 1 provider may exclude if not planned selection (2015 only) • Summary of Care (Electronic exchange) ▪ Stage 1 provider may exclude (2015 only) • Secure Messages ▪ Objective changed to self-attestation. ▪ Stage 1 provider may exclude (2015 only)
  • 40. 2015 Proposed Rule for Meaningful Use Public Health Objectives • Stage 1 provider must successfully report on ‘1’ objective (unless all exclusions met, 2015 only). • Stage 2 provider must successfully report on ‘2’ objectives (unless exclusions met and provider has less than 2 options) 5/15/2015 MU 2 & PQRS Seminar 40 Measure Times Measure Can Count Immunization Registry 1 Syndromic Surveillance 1 Case Reporting (new) 1 Public Health Registry (cancer, etc.) 3 Clinical Data Registry Reporting (specialty registry) 3
  • 41. Minimal products necessary to help demonstrate Stage 2 Meaningful Use if using only NextGen solutions: • NextGen® Ambulatory EHR 5.8 ▪ e-Prescribing enabled ▪ NextGen Advanced Audit Utility NextGen® KBM version 8.3 or higher NextGen® Health Quality Measures (HQM) Rosetta Interface Agent • Immunization registry interface • Syndromic reporting interface (if Menu Measure 1 selected) • Cancer Case interface (if Menu Measure 5 selected) • Specialized Registry interface (if Menu Measure 6 selected) NextGen® Medical Summary Utility NextGen® Patient Portal (powered by NextMD®) NextGen® Share 5/15/2015 MU 2 & PQRS Seminar 41
  • 42. White Pages Manual Nextgen Website: https://knowledge.nextgen.com/pe/action/forums/navigateresults Download each white page Use program to attach white page into 1 manual such as PDFil Have a separate manual for CQM from Menu and Cores 5/15/2015 MU 2 & PQRS Seminar 42
  • 43. The National Quality Strategy (NQS) In 2015, measures are classified according to the 6 NQS domains based on the NQS’s priorities. PQRS reporting options typically require an EP or PQRS group practice to report 9 or more measures covering at least 3 NQS domains, plus additional cross-cutting measures for EPs with billable face-to-face encounters for satisfactory reporting or participation to avoid the 2017 negative payment adjustment. The Six NQS Domains: 1. Patient Safety 2. Person and Caregiver-Centered Experience and Outcomes 3. Communication and Care Coordination 4. Effective Clinical Care 5. Community/ Population Health 6. Efficiency and Cost Reduction 5/15/2015 MU 2 & PQRS Seminar 43
  • 44. PQRS INDIVIDUAL EPs 1. Report on at least 9 measures across at least 3 National Quality Strategy (NQS) domains 2. Use a direct EHR product that is Certified EHR Technology (CEHRT) or EHR data submission vendor that is CEHRT • If the EP’s CEHRT does not contain patient data for at least 9 measures across at least 3 domains, then the EP must report the measures for which there is Medicare patient data. An EP must report on at least 1 measure containing Medicare patient data. Note for EHR Incentive Program participants: If an EP satisfactorily reports for 2015 PQRS using the electronic reporting option, (s)he will also satisfy the CQM component of the EHR Incentive program; however, EPs will still be required to meet the other Meaningful Use objectives through the Medicare EHR Incentive Program Registration and Attestation System. 5/15/2015 MU 2 & PQRS Seminar 44
  • 45. 2013 0.5% (performance year for 2015 penalty) 2014 0.5% (performance year for 2016 penalty) 2015 -1.5% 2016 -2% 2017 -2% Medicare Physician Quality Reporting System Incentives and Penalties 5/15/2015 MU 2 & PQRS Seminar 45
  • 46. 46
  • 47. Reference http://www.ama-assn.org/ama/pub/physician-resources/clinical-practice-improvement/clinical- quality/physician-quality-reporting-system.page? 2015 Physician Quality Reporting System (PQRS): Implementation Guide 1/15/2015 , CMS Stage 1 vs. Stage 2 Comparison Table for Eligible Professionals , CMS MU Core and menu objectives Manual, Nextgen Nextgen E-Learning 5/15/2015 MU 2 & PQRS Seminar 47